Cargando…
血友病A患儿凝血因子Ⅷ抑制物相关临床研究
OBJECTIVE: To reveal the related factors of inhibitors and differences ofhemorrhage and joint disease before and after the production of inhibitors in children with hemophilia A (HA). METHODS: Retrospective analyses of the clinical data of 381 children with HA under the age of 16 registered in the R...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357942/ https://www.ncbi.nlm.nih.gov/pubmed/32135631 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.02.010 |
Ejemplares similares
-
26例血友病A伴抑制物患儿的危险因素分析及随访研究
Publicado: (2016) -
国产血源性人凝血因子Ⅸ治疗血友病B的多中心Ⅲ期临床研究
Publicado: (2018) -
重组活化凝血因子Ⅶ联合凝血酶原复合物在血友病A伴高滴度抑制物患者围手术期的应用
Publicado: (2020) -
一个血友病A家系的凝血因子Ⅷ基因突变分析
Publicado: (2016) -
两种重组人凝血因子Ⅷ制剂在血友病A患者中的群体药代动力学研究
por: Chelle, Pierre, et al.
Publicado: (2019)